TUMORI, vol.90, no.2, pp.192-195, 2004 (SCI-Expanded)
Aim: To determine the activity and toxicity of a combination of weekly gemcitabine and 5-fluorouracil bolus intravenously in patients with metastatic pancreatic cancer.